Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HES3-dependent regulatory functions in development and fusion-positive rhabdomyosarcoma.

bioRxiv : the preprint server for biology·2026
Same author

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Cancers·2026
Same author

Comparative modes of chromatin engagement by PAX::FOXO1 fusions in rhabdomyosarcoma.

bioRxiv : the preprint server for biology·2026
Same author

RNA-SeqEZPZ: a point-and-click pipeline for comprehensive transcriptomics analysis with interactive visualizations.

GigaScience·2025
Same author

Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo.

Cell reports·2025
Same author

Fusion oncogenes in rhabdomyosarcoma: model systems, mechanisms of tumorigenesis, and therapeutic implications.

Frontiers in oncology·2025

Related Experiment Video

Updated: Jul 17, 2025

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

11.2K

Functional Genomics of Novel Rhabdomyosarcoma Fusion-Oncogenes Using Zebrafish.

Matthew R Kent1, Katherine Silvius1, Jack Kucinski1,2

  • 1Center for Childhood Cancer & Blood Diseases, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.

Methods in Molecular Biology (Clifton, N.J.)
|September 5, 2023
PubMed
Summary
This summary is machine-generated.

Researchers developed a zebrafish model to test new cancer-causing genes (oncogenes) found in rhabdomyosarcoma (RMS). This rapid system validates fusion-oncogenes and explores therapeutic targets.

Keywords:
Functional genomicsFusion-oncogenePediatric sarcomaRhabdomyosarcomaZebrafish cancer models

More Related Videos

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

2.8K
Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish
09:39

Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish

Published on: December 26, 2014

11.0K

Related Experiment Videos

Last Updated: Jul 17, 2025

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

11.2K
Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

2.8K
Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish
09:39

Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish

Published on: December 26, 2014

11.0K

Area of Science:

  • Oncology
  • Genetics
  • Zebrafish Modeling

Background:

  • Clinical sequencing identifies novel oncogenes, but in vivo functional validation remains challenging.
  • Rhabdomyosarcoma (RMS) tumorigenesis is often driven by fusion-oncogenes requiring robust experimental models.
  • Understanding fusion-oncogene mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To present a pipeline for in vivo modeling of fusion-driven rhabdomyosarcoma using transgenic zebrafish.
  • To functionally validate novel fusion-oncogenes identified from patient samples.
  • To investigate the mechanisms of tumorigenesis driven by specific fusion-oncogenes.

Main Methods:

  • Integration of human fusion-oncogenes identified from RMS patient samples into the zebrafish genome.
  • Development of transgenic zebrafish systems for in vivo modeling.
  • Characterization of tumor formation driven by the integrated fusion-oncogenes.

Main Results:

  • Successful establishment of zebrafish models for infantile and alveolar rhabdomyosarcoma.
  • Demonstrated that fusion-oncogenes like VGLL2-NCOA2 and PAX3-FOXO1 drive RMS tumor formation in vivo.
  • The zebrafish platform enables rapid assessment of fusion-oncogene impact and shared/divergent biology.

Conclusions:

  • The described zebrafish platform offers a rapid and effective method for in vivo functional validation of fusion-oncogenes in rhabdomyosarcoma.
  • This model facilitates the study of fusion-oncogene biology and identification of convergent pathways for potential therapeutic targets.
  • This approach advances the understanding and treatment strategies for fusion-driven RMS.